B:Live, India’s fastest-growing multi-brand EV platform, has partnered with Medikabazaar – India’s leading medical marketplace, to help the latter adopt EVs for its delivery operations. The deployment of electric two-wheelers represents a significant shift towards sustainable mobility solutions. By opting for EV 2-wheelers, Medikabazaar aims to reduce carbon emissions and promote eco-friendly transportation alternatives.
The enthusiastic response from riders and the positive impact on the environment has further fuelled its commitment to expanding the initiative. The first batch of EV 2Ws has been delivered to their respective hubs in Mumbai, Pune, Hyderabad, Bengaluru, Kolkata, Delhi-NCR, Gurgaon, and Ahmedabad. These locations will ensure overall accessibility and convenience for riders in metropolitan areas.
Speaking about the collaboration, Samarth Kholkar, CEO & Co-Founder, B:Live, said “It gives me immense pleasure to join hands with Medikabazaar and facilitate the delivery of medicines while protecting the environment. This collaboration is aimed at furthering our cause for greater adoption of EVs in the country. With a focus on electric vehicles for their Last mile delivery solutions Medikabazaar can make use of electric vehicles to significantly reduce the cost of operation, making EVs a winning proposition.”
Medikabazaar was looking for a solution to the evolving market demands, particularly in the context of fast deliveries in hospitals, With increasing competition in the market, the company recognized the importance of providing swift delivery services through its fulfillment centres, in a cost-effective and sustainable way. As a solution, BLive offered the company a rental solution within their price range that will not only reduce Medikabazaar’s running costs by close to 80% but also make them one of the early medical chains to go green, that is, 100% replacement of ICE vehicles with EVs.
Speaking about the partnership with B:Live, Mr. Manish Gahlaut, COO Medikabazaar, says, “We are extremely excited to partner with B:Live and utilise their expertise in sustainable mobility. As a responsible corporate it was crucial for us to explore smart , sustainable green mobility solutions to optimise our delivery processes. We sought B:Live’s expertise in having a tailored solution and tap into the advantages offered by EVs, such as lower operating costs and reduced carbon emissions.”
The partnership between B:Live and Chartered Bike Pvt Ltd (CBPL) is aimed at helping last-mile delivery companies, such as Medikabazaar and many more, to resolve the supply gap of electric vehicles in the market. The collaboration between B:Live and CBPL aims to resolve this issue by helping organizations like Medikabazaar deploy vehicles nationwide, with a focus on Tier II cities. Looking ahead, B:Live has scheduled the second phase for the next quarter (Q3), with plans to convert an additional 20% of the fleet into EV 2Ws. This will result in a remarkable milestone of 50% of Medikabazaar fleet size conversion into electric vehicles.
B:Live is India’s first Multi-brand EV platform offering a wide range of EV products and services on a digital platform www.B:LiveEVstore.com With over 40 brands listed on its platform, B:Live offers an omnichannel experience to its buyers – an online E-commerce store and Premium experience stores pan India. Driving its vision to accelerate adoption of EVs – B:Live is rapidly expanding its presence pan India to 100 premium Multi-brand Stores by ’24 offering E-Scooters/ E-cycles/ Delivery Ebikes and many more unique form factors. B:Live facilitates EV adoption for personal usage as well as businesses by providing seamless Charging infrastructure, Post sales service as well as easy finance options to its customers.
Medikabazaar is India’s largest online B2B platform for medical supplies. With our online platform, last-mile delivery, AI-ML application, and other value-added services, hospitals can procure their supplies via a streamlined procurement system while delivering affordable and accessible healthcare for patients in India.